Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Titel:
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Auteur:
Roghanian, Ali Teige, Ingrid Mårtensson, Linda Cox, Kerry L. Kovacek, Mathilda Ljungars, Anne Mattson, Jenny Sundberg, Annika Vaughan, Andrew T. Shah, Vallari Smyth, Neil R. Sheth, Bhavwanti Chan, H.T. Claude Li, Zhan-Chun Williams, Emily L. Manfredi, Giusi Oldham, Robert J. Mockridge, C. Ian James, Sonya A. Dahal, Lekh N. Hussain, Khiyam Nilsson, Björn Verbeek, J. Sjef Juliusson, Gunnar Hansson, Markus Jerkeman, Mats Johnson, Peter W.M. Davies, Andrew Beers, Stephen A. Glennie, Martin J. Frendéus, Björn Cragg, Mark S.